A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 252

Filename: relationship_parser/Parser.php

Line Number: 52

Health Economics and Outcomes Research | Avalere Health
Avalere Health
An Inovalon Company
Services

Health Economics & Outcomes Research

Deliver Evidence

Heightened demands from patients, payers and providers for more information on cost, quality, and outcomes continue to elevate the evidentiary bar. The flood of real world data, clinical trial results, registries, and other data sources creates risks and opportunities as all of this information shapes coverage and treatment decisions, defines value, and impacts patient access. Equipped with a deep understanding of the policy landscape, payer evidentiary demands, and provider behavior, Avalere provides insight on the challenges and opportunities that exist within this space. We combine our broad health economics and outcomes research (HEOR) experience, clinical expertise, payer and provider knowledge, and analytical capabilities to deliver breakthrough evidence generation strategies.

What's Your Challenge?

  • ​Evidence Generation Strategies
  • ​Value Proposition Development
  • ​Observational Research
  • ​Health Economic Models

Complementary Products

Team

Meet a few of our experts ready to partner with you.

All Staff

Michael Johnsrud

Senior Vice President

Michael
Johnsrud

Michael Johnsrud, Senior Vice President, leads our health economics and outcomes research group. He provides guidance to clients by helping them create strategies to generate the needed clinical and economic evidence to inform stakeholders in the marketplace. In addition, he designs and conducts studies to analyze how prescription drugs, medical devices, and various interventions impact resource utilization and patient quality of life. Michael has particular expertise in prescription reimbursement policy in Medicaid, Medicare, and private-sector plans, and the economics of the marketplace for community pharmacy and prescription drug benefit programs.

Prior to joining Avalere, Mike was Associate Director of The Center for Pharmacoeconomic Studies at the University of Texas at Austin. Mike received an Award of Excellence from the Journal of Managed Care Pharmacy for research that used prescription drug claims to determine differences in medication payment and utilization between pharmacy delivery channels.

Mike has a BS in Pharmacy from the University of Iowa and a MS and PhD in Pharmacy Administration from the University of Texas at Austin.  He is a registered pharmacist.

Tiernan Meyer

Manager

Tiernan
Meyer

Tiernan Meyer, Manager, supports Avalere clients in analytic and strategic engagements focused on Medicaid, state health policy trends, and the impact of federal health reform. Tiernan leads Avalere’s Medicaid policy tracking—including states’ decisions around expanding Medicaid under the Affordable Care Act—and our analysis of trends and enrollment in Medicaid managed care.  She follows Medicaid trends with a particular focus on pharmaceuticals and state cost containment, and has expertise in private exchanges and benefit design trends.

Prior to joining Avalere, Tiernan worked as a health educator at the Delta Area Health Education Center in Helena, AR. Additionally, she analyzed the Chilean public healthcare system while studying in Concepción, Chile.

Tiernan has a BA in neuroscience from Middlebury College.

Barnabie Agatep

Senior Manager

Barnabie
Agatep

Barnabie Agatep, Senior Manager, advises clients on health economic and outcomes research initiatives that support product commercialization and demonstrate client product/service value.  Barnabie also has experience conducting retrospective database analyses and evaluating Quality Measures for specific therapeutic areas.

Prior to joining Avalere, Barnabie served as a Senior Manager in Health Economics and Outcomes Research at the Medco Research Institute and as a Research Associate for Pfizer Inc., Global Outcomes Research.  At Medco, Barnabie developed economic models and conducted retrospective research analyses to illustrate the cost-effectiveness and value of pharmacogenomics and personalized medicine. At Pfizer, Barnabie assisted in drafting product dossiers, pharmacoeconomics research analysis, and other outcomes research initiatives in support of launching and pre-existing urology products.

Barnabie has a BS in Public Health from The Richard Stockton College of New Jersey and a MPH in Epidemiology from the University of Medicine and Dentistry of New Jersey – School of Public Health.

« Back to Mobile Site